Johnson & Johnson (JNJ) announced results from the Phase 3 CEPHEUS study demonstrating a significant clinical improvement with ...
Janssen-Cilag International NV, a Johnson & Johnson company, announced three-year follow-up data from the Phase 3 CARTITUDE-4 study ...
It starts in the lymphocytes, a type of white blood cell, and typically forms tumours in the lymph nodes. The two main types are Multiple myeloma is cancer of the plasma cells in the bone marrow.